GPRC5D-Targeted CAR T Cells for Myeloma

Overview of attention for article published in New England Journal of Medicine, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news: 33 news outlets
blogs: 4 blogs
twitter: 133 X users
patent: 20 patents

facebook: 1 Facebook page
guideline: 2 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 229 Mendeley

So far, Altmetric has seen 20 patents that reference this research output.

METHODS OF TREATMENT WITH GPRC5D ANTIBODIES WITH ENHANCED EFFECTOR FUNCTION

Application WO-2026044177-A1

World Intellectual Property Organisation (WIPO)

26 Feb 2026

CHIMERIC ANTIGEN RECEPTOR TARGETING GPRC5D AND APPLICATION THEREOF

Application EP-4497759-A4

European Patent Office

11 Feb 2026

IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES

Application WO-2025217454-A2

World Intellectual Property Organisation (WIPO)

16 Oct 2025

CONSTRAINED IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES

Application WO-2025217452-A1

World Intellectual Property Organisation (WIPO)

16 Oct 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 16 additional patents.